Financials Lunit Inc.

Equities

A328130

KR7328130000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E. 03:30:00 17/05/2024 am IST 5-day change 1st Jan Change
54,700 KRW +0.37% Intraday chart for Lunit Inc. -1.97% -33.21%

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 3,64,383 23,32,210 15,77,035 -
Enterprise Value (EV) 2 364.4 2,332 1,407 1,397
P/E ratio -7.95 x - - -
Yield - - - -
Capitalization / Revenue - 93 x 29.5 x 16.4 x
EV / Revenue - 93 x 26.3 x 14.5 x
EV / EBITDA - -60.7 x -107 x 59.3 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - 7.34 x 6.95 x
Nbr of stocks (in thousands) 24,455 28,476 28,831 -
Reference price 3 14,900 81,900 54,700 54,700
Announcement Date 21/03/23 15/02/24 - -
1KRW in Million2KRW in Billions3KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 25.08 53.55 96.38
EBITDA 1 - -38.44 -13.15 23.55
EBIT 1 - -42.18 -15.22 22.9
Operating Margin - -168.19% -28.42% 23.77%
Earnings before Tax (EBT) - - - -
Net income 1 -39.12 -36.75 -15.73 12.2
Net margin - -146.52% -29.38% 12.66%
EPS -1,874 - - -
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - - - -
Announcement Date 21/03/23 15/02/24 - -
1KRW in Billions2KRW
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2
Net sales 1 - 5.445
EBITDA - -
EBIT 1 - -10.04
Operating Margin - -184.46%
Earnings before Tax (EBT) 1 - -9.996
Net income 1 -2.086 -9.996
Net margin - -183.56%
EPS -85.00 -
Dividend per Share - -
Announcement Date 10/05/23 11/08/23
1KRW in Billions
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt 1 - - - -
Net Cash position 1 - - 170 180
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - -24.2% -7.1% 5.55%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - - 7,448 7,873
Cash Flow per Share 2 - - -476.0 448.0
Capex - - - -
Capex / Sales - - - -
Announcement Date 21/03/23 15/02/24 - -
1KRW in Billions2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
54,700 KRW
Average target price
1,00,000 KRW
Spread / Average Target
+82.82%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW